首页> 美国卫生研究院文献>other >Development and Characterization of a Standardized ELISA Including a Reference Serum on Each Plate to Detect Antibodies Induced by Experimental Malaria Vaccines
【2h】

Development and Characterization of a Standardized ELISA Including a Reference Serum on Each Plate to Detect Antibodies Induced by Experimental Malaria Vaccines

机译:标准化ELISA的开发和表征包括在每块板上的参考血清以检测实验性疟疾疫苗诱导的抗体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enzyme linked immunosorbent assay (ELISA) has been widely used to measure antibody titers for evaluating the immunogenicity of a vaccine. However, there is as yet no generally accepted way of expressing the ELISA results in the case of experimental vaccines, since there is usually no uniform standard. Both end point and single dilution methods have significant disadvantages. In this paper, we obtained reproducible data with fewer dilutions of samples by addition of serially diluted standard serum to each ELISA plate. Since this ELISA method gives reliable antibody titer with less labor than other methods, it can strongly support vaccine development.
机译:酶联免疫吸附测定(ELISA)已广泛用于测量抗体效价,以评估疫苗的免疫原性。然而,由于通常没有统一的标准,在实验疫苗的情况下,目前尚没有公认的表达ELISA结果的方法。终点法和单一稀释法均具有明显的缺点。在本文中,通过向每个ELISA板中添加系列稀释的标准血清,我们获得了具有更少样品稀释度的可再现数据。由于这种ELISA方法比其他方法可提供可靠的抗体滴度和更少的工作量,因此可以大力支持疫苗的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号